BHVN
Price
$13.14
Change
+$1.22 (+10.23%)
Updated
Jan 16 closing price
Capitalization
1.74B
60 days until earnings call
Intraday BUY SELL Signals
CGON
Price
$54.73
Change
+$1.66 (+3.13%)
Updated
Jan 16 closing price
Capitalization
4.52B
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BHVN vs CGON

Header iconBHVN vs CGON Comparison
Open Charts BHVN vs CGONBanner chart's image
Biohaven
Price$13.14
Change+$1.22 (+10.23%)
Volume$4.13M
Capitalization1.74B
CG Oncology
Price$54.73
Change+$1.66 (+3.13%)
Volume$1.05M
Capitalization4.52B
BHVN vs CGON Comparison Chart in %
BHVN
Daily Signal:
Gain/Loss:
CGON
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BHVN vs. CGON commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHVN is a Hold and CGON is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (BHVN: $13.14 vs. CGON: $54.73)
Brand notoriety: BHVN and CGON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BHVN: 107% vs. CGON: 101%
Market capitalization -- BHVN: $1.74B vs. CGON: $4.52B
BHVN [@Biotechnology] is valued at $1.74B. CGON’s [@Biotechnology] market capitalization is $4.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHVN’s FA Score shows that 0 FA rating(s) are green whileCGON’s FA Score has 0 green FA rating(s).

  • BHVN’s FA Score: 0 green, 5 red.
  • CGON’s FA Score: 0 green, 5 red.
According to our system of comparison, BHVN is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHVN’s TA Score shows that 6 TA indicator(s) are bullish while CGON’s TA Score has 6 bullish TA indicator(s).

  • BHVN’s TA Score: 6 bullish, 3 bearish.
  • CGON’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BHVN is a better buy in the short-term than CGON.

Price Growth

BHVN (@Biotechnology) experienced а +18.27% price change this week, while CGON (@Biotechnology) price change was +0.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

BHVN is expected to report earnings on Mar 19, 2026.

CGON is expected to report earnings on Mar 27, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($4.52B) has a higher market cap than BHVN($1.74B). CGON YTD gains are higher at: 31.816 vs. BHVN (16.386). CGON has higher annual earnings (EBITDA): -179.53M vs. BHVN (-782.76M). CGON has more cash in the bank: 680M vs. BHVN (260M). CGON has less debt than BHVN: CGON (7.24M) vs BHVN (314M). CGON has higher revenues than BHVN: CGON (2.17M) vs BHVN (0).
BHVNCGONBHVN / CGON
Capitalization1.74B4.52B39%
EBITDA-782.76M-179.53M436%
Gain YTD16.38631.81652%
P/E RatioN/AN/A-
Revenue02.17M-
Total Cash260M680M38%
Total Debt314M7.24M4,336%
FUNDAMENTALS RATINGS
BHVN: Fundamental Ratings
BHVN
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BHVNCGON
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 12 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BHVN
Daily Signal:
Gain/Loss:
CGON
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KLCAX14.480.06
+0.42%
Federated Hermes Kaufmann Large Cap A
LFFLX16.390.03
+0.18%
Lord Abbett Focused Large Cap Value F
PEQRX39.960.01
+0.03%
Putnam Large Cap Value R
FMDGX36.20-0.07
-0.19%
Fidelity Mid Cap Growth Index
NCLEX26.43-0.17
-0.64%
Nicholas Limited Edition I

BHVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with SYRE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+10.23%
SYRE - BHVN
47%
Loosely correlated
+0.45%
BCYC - BHVN
45%
Loosely correlated
+0.62%
VCYT - BHVN
43%
Loosely correlated
+1.39%
TERN - BHVN
43%
Loosely correlated
-1.03%
CGON - BHVN
43%
Loosely correlated
+3.13%
More

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with RVMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+3.13%
RVMD - CGON
54%
Loosely correlated
-2.43%
IDYA - CGON
53%
Loosely correlated
-0.61%
NUVL - CGON
53%
Loosely correlated
-1.79%
SYRE - CGON
53%
Loosely correlated
+0.45%
XNCR - CGON
51%
Loosely correlated
-3.18%
More